Efficacy of serum anti-mullerian hormone (AMH) levels for prediction of polycystic ovary syndrome (PCOS) and its association with clinical, biochemical and hormonal parameters

被引:6
作者
Sumji, Sajad [1 ]
Bhat, Abid [1 ]
Rashid, Aafia [1 ,2 ]
Bashir, Rohina [1 ,2 ]
Wani, Imtiyaz A. [1 ,2 ]
Vasudevan, Vishnu [1 ]
Sehar, Tajali [1 ,2 ]
Ganie, Mohd Ashraf [1 ,2 ]
机构
[1] Sherikashmir Inst Med Sci, Dept Endocrinol, Srinagar, Jammu & Kashmir, India
[2] Sherikashmir Inst Med Sci, Dept Clin Res, Srinagar 190011, India
关键词
Anti-mullerian hormone (AMH); Polycystic ovarian morphology (PCOM); Rotterdam criteria; Hyperandrogenism; Oligo; amenorrhea; ANTIMULLERIAN HORMONE; ANTRAL FOLLICLE; DIAGNOSIS; MORPHOLOGY; COUNT; WOMEN; DEFINITION; TOOL;
D O I
10.1007/s12291-022-01058-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Anti-mullerian hormone (AMH) has been proposed to add significance to diagnosis of PCOS in case of ambiguity. However, variable cutoffs of AHM among PCOS women have been reported. Using case-control design, this study investigated the diagnostic threshold of serum AMH levels among age matched 113 PCOS and 75 normo-ovulatory women and its correlation with clinical, hormonal and ultrasonographic parameters.PCOS was defined as per Rotterdam criteria 2003. Results depicted the mean serum AMH level to be significantly higher in PCOS group (7.84 +/- 3.67vs. 3.23 +/- 1.56 ng/mL) than controls. The AMH levels were positively(p = 0.001) associated with ovarian volume (r = 0.521) as well as number of ovarian follicles(r = 0.461). Further, serum AMH levels showed a positive correlation with luteinizing hormone/follicle stimulating hormone (LH/FSH) ratio (r = 0.206, p = 0.02), but no correlation significant with age, BMI,FG score and testosterone levels. As per receiver operating characteristic (ROC) curve, cut-off was worked out to be 3.76 ng/ml with 86.7% sensitivity and 62.7% specificity. The mean level of AMH were highest among PCOS women with phenotype A (12.67 +/- 3.46 ng/ml) with least among PCOS women displaying phenotype B(7.28 +/- 1.60 ng/ml) where there is absence of PCOM. In conclusion, serum AMH levels are highly predictive of PCOM and high LH/FSH ratio among PCOS women and may be a potent diagnostic marker of ovarian dysfunction either alone or in conjunction with other tools.
引用
收藏
页码:457 / 465
页数:9
相关论文
共 29 条
[1]   Serum Anti-Mullerian Hormone in the Diagnosis of Polycystic Ovary Syndrome in Association with Clinical Symptoms [J].
Ahmed, Nada ;
Batarfi, Asma A. ;
Bajouh, Osama S. ;
Bakhashab, Sherin .
DIAGNOSTICS, 2019, 9 (04)
[2]   Can we use serum Anti-Mullerian hormone to differentiate the diagnosis between polycystic ovary syndrome patients and healthy women with polycystic ovarian morphology and regular menstrual cycles [J].
Aydogmus, Huseyin ;
Kelekci, Sefa ;
Elmali, Ferhan ;
Aydogmus, Serpil .
SAUDI MEDICAL JOURNAL, 2018, 39 (10) :1011-1016
[3]   Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimullerian hormone than its counterpart in a normal ovary: an observational cross-sectional study [J].
Bhide, Priya ;
Dilgil, Merve ;
Gudi, Anil ;
Shah, Amit ;
Akwaa, Charity ;
Homburg, Roy .
FERTILITY AND STERILITY, 2015, 103 (02) :537-541
[4]   Anti-Mullerian hormone serum level as a predictive marker of ovarian function in Taiwanese women [J].
Chao, Kuan-Chong ;
Ho, Chi-Hong ;
Shyong, Wen-Yuann ;
Huang, Chen-Yu ;
Tsai, Shu-Chuan ;
Cheng, Hsin-Yi ;
Chou, Luoh-Chyi ;
Lin, Chih-Hsiu ;
Li, Hsin-Yang .
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2012, 75 (02) :70-74
[5]   Antimullerian hormone to determine polycystic ovarian morphology [J].
de Loos, Alexandra Dietz ;
Hund, Martin ;
Buck, Katharina ;
Meun, Cindy ;
Sillman, Johanna ;
Laven, Joop S. E. .
FERTILITY AND STERILITY, 2021, 116 (04) :1149-1157
[6]   Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries [J].
Dewailly, D. ;
Gronier, H. ;
Poncelet, E. ;
Robin, G. ;
Leroy, M. ;
Pigny, P. ;
Duhamel, A. ;
Catteau-Jonard, S. .
HUMAN REPRODUCTION, 2011, 26 (11) :3123-3129
[7]   Role of Anti-Mullerian Hormone in pathophysiology, diagnosis and treatment of Polycystic Ovary Syndrome: a review [J].
Dumont, Agathe ;
Robin, Geoffroy ;
Catteau-Jonard, Sophie ;
Dewailly, Didier .
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY, 2015, 13
[8]   Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome: can morphologic description be replaced? [J].
Eilertsen, Tina B. ;
Vanky, Eszter ;
Carlsen, Sven M. .
HUMAN REPRODUCTION, 2012, 27 (08) :2494-2502
[9]   Serum antimullerian hormone (AMH) levels are elevated in adolescent girls with polycystic ovaries and the polycystic ovarian syndrome (PCOS) [J].
Hart, Roger ;
Doherty, Dorota A. ;
Norman, Robert J. ;
Franks, Stephen ;
Dickinson, Jan E. ;
Hickey, Martha ;
Sloboda, Deborah M. .
FERTILITY AND STERILITY, 2010, 94 (03) :1118-1121
[10]   The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study [J].
Homburg, R. ;
Ray, A. ;
Bhide, P. ;
Gudi, A. ;
Shah, A. ;
Timms, P. ;
Grayson, K. .
HUMAN REPRODUCTION, 2013, 28 (04) :1077-1083